# Treatment of Supine Hypertension in Autonomic Failure (CPAP)

> **NCT03312556** · NA · RECRUITING · sponsor: **Vanderbilt University Medical Center** · enrollment: 12 (estimated)

## Conditions studied

- Supine Hypertension
- Autonomic Failure

## Interventions

- **DEVICE:** continuous positive airway pressure (CPAP)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03312556
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-09-21
- **Primary completion:** 2026-09-21
- **Final completion:** 2026-12-21
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03312556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03312556, "Treatment of Supine Hypertension in Autonomic Failure (CPAP)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03312556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*